Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Allergan
|
| gptkbp:application |
topical
apply to base of eyelashes |
| gptkbp:approves |
gptkb:2001
gptkb:FDA |
| gptkbp:brand |
gptkb:Latisse
|
| gptkbp:clinical_trial |
gptkb:skincare_product
Phase 3 studied for efficacy showed significant eyelash growth |
| gptkbp:contraindication |
hypersensitivity to bimatoprost
|
| gptkbp:demographics |
adults
|
| gptkbp:dosage_form |
once daily
|
| gptkbp:duration |
at least 8 weeks for results
|
| gptkbp:feedback |
generally positive
|
| gptkbp:form |
eyelash serum
|
| gptkbp:frequency |
daily
|
| https://www.w3.org/2000/01/rdf-schema#label |
Latisse
|
| gptkbp:ingredients |
gptkb:bimatoprost
gptkb:edetate_disodium gptkb:item gptkb:benzalkonium_chloride citric acid preservatives sodium chloride sodium phosphate prostaglandin analog |
| gptkbp:invention |
patented
|
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_effective_against |
promotes eyelash growth
|
| gptkbp:is_used_for |
hypotrichosis
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:marketed_as |
cosmetic use
eyelash enhancement product |
| gptkbp:packaging |
bottle with applicators
|
| gptkbp:price |
varies by pharmacy
|
| gptkbp:products |
gptkb:Lumigan
|
| gptkbp:release_date |
evening
|
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:safety_features |
generally safe
|
| gptkbp:side_effect |
allergic reaction
dry eyes eye irritation redness of the eye darkening of eyelid skin eyelash changes increased brown pigmentation of iris |
| gptkbp:storage |
room temperature
|
| gptkbp:suitable_for |
pregnant women
nursing mothers under 16 years old people with allergies to ingredients people with active eye conditions people with certain eye surgeries people with eye infections |